(Q45074770)

English

Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin.

scientific article published on 12 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998288%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998288%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Joseph S Solomkin

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998288%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Ellie J. C. Goldstein

1

object named as

Ellie J C Goldstein

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998288%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Diane M. Citron

3

object named as

Diane M Citron

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998288%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Jeffrey D Alder

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998288%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

language of work or name

0 references

publication date

12 October 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998288%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Clinical Infectious Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998288%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

53

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998288%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998288%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1074-1080

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998288%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Microbiology of polymicrobial abscesses and implications for therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patterns

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Susceptibility of the Bacteroides fragilis group to newer quinolones and other standard anti-anaerobic agents

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Comparative in vitro activities of gemifloxacin, other quinolones, and nonquinolone antimicrobials against obligately anaerobic bacteria

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

In vitro activities of newer quinolones against bacteroides group organisms

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Emergence of fluoroquinolone resistance among Bacteroides species

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007)

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Pharmacokinetics and tissue penetration of moxifloxacin in intervention therapy for intra-abdominal abscess

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Serum bactericidal activities of moxifloxacin and levofloxacin against aerobic and anaerobic intra-abdominal pathogens

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study).

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Anaerobes: antibiotic resistance, clinical significance, and the role of susceptibility testing

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

German multicentre survey of the antibiotic susceptibility of Bacteroides fragilis group and Prevotella species isolated from intra-abdominal infections: results from the PRISMA study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR664

21 January 2018

Identifiers

10.1093/CID/CIR664

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998288%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998288%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45074770&oldid=2068525803"